Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
![Foto de Terapia Génica en Enfermedad de Parkinson](/img/uploaded/2e47307b33b4171dbd01aab57609e63c.jpg)
![Foto de Universidad Miguel Hernández de Elche](/img/noimage_org.png)
Universidad Miguel Hernández de Elche
Elche, EspañaUniversidad Miguel Hernández de Elche-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2018
-
Alterations in Gene and Protein Expression of Cannabinoid CB 2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
Neurotherapeutics, Vol. 15, Núm. 3, pp. 796-806
-
Cannabinoid cb1 and cb2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with parkinson’s disease
Neurotherapeutics, Vol. 15, Núm. 2, pp. 459-469
2016
-
Increased vulnerability to ethanol consumption in adolescent maternal separated mice
Addiction Biology, Vol. 21, Núm. 4, pp. 847-858
2002
-
Chemoreceptor activity is normal in mice lacking the NK1 receptor
European Journal of Neuroscience, Vol. 16, Núm. 11, pp. 2078-2084
-
The Use of NK-1 Receptor Null Mice to Assess the Significance of Substance P in the Carotid Body Function
Advances in Experimental Medicine and Biology